BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
3.615
+0.135 (3.88%)
Feb 5, 2025, 10:58 AM EST - Market open
BioLineRx Employees
BioLineRx had 79 employees as of December 31, 2023. The number of employees increased by 30 or 61.22% compared to the previous year.
Employees
79
Change (1Y)
30
Growth (1Y)
61.22%
Revenue / Employee
$278,367
Profits / Employee
-$252,127
Market Cap
13.16M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
BLRX News
- 15 days ago - BioLineRx Issues Letter to Shareholders - PRNewsWire
- 19 days ago - BioLineRx Announces Change to Ratio of American Depositary Shares to Ordinary Shares - PRNewsWire
- 4 weeks ago - Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet - Benzinga
- 4 weeks ago - BioLineRx Announces $10 Million Registered Direct Offering - PRNewsWire
- 2 months ago - BioLineRx Ltd. (BLRX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - BioLineRx Reports Third Quarter 2024 Financial Results and Provides Update on Transformation to Drive Shareholder Value - PRNewsWire
- 2 months ago - BioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA® (motixafortide) through Gamida Cell Ltd. - PRNewsWire
- 2 months ago - BioLineRx to Report Third Quarter 2024 Results on November 25, 2024 - PRNewsWire